» Articles » PMID: 11681713

Functional Properties of the Rat Phosphatase 1alpha Promoter

Overview
Publisher Springer
Specialty Biochemistry
Date 2001 Oct 30
PMID 11681713
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the functional properties of the promoter of the protein phosphatase 1alpha catalytic subunit. Luciferase plasmids with different fragments of the rat catalytic subunit of the protein phosphatase 1alpha promoter ranging from -3.7 kbp to -59 bp were transiently transfected into cells by the calcium-phosphate precipitation method. The promoter activity was determined in the absence and presence of inotropic agents which influencing the cAMP-depending pathway. The basal transcriptional activity decreased at fragment -124 bp and shorter fragments. To identify regions of regulatory importance we investigated the cAMP-dependent influence on the transcriptional activity. Stimulation of the complete promoter region with forskolin (1-100 microM) for 6 h led to a concentration-dependent decrease of transcriptional activity. Moreover, regions shorter than 3.7 kbp were inhibited by forskolin (10 microM). Short time stimulation (10 min) with forskolin (10 microM) increased the transcriptional activity of only the 3.7 kbp fragment. The effects were antagonized by Rp-cAMPS, a specific antagonist of protein kinase A, indicating cAMP-dependent effects. The results provide evidence for cAMP-dependent regulation of the protein phosphatase 1alpha promotor.

Citing Articles

Cantharidin increases the force of contraction and protein phosphorylation in isolated human atria.

Schwarz R, Hofmann B, Gergs U, Neumann J Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(10):2613-2625.

PMID: 37097333 PMC: 10497697. DOI: 10.1007/s00210-023-02483-9.

References
1.
Hasenfuss G . Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998; 37(2):279-89. DOI: 10.1016/s0008-6363(97)00277-0. View

2.
Knapp J, Boknik P, Linck B, Luss H, Muller F, Nacke P . The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoceptor-mediated vasorelaxation. Br J Pharmacol. 1997; 120(3):421-8. PMC: 1564485. DOI: 10.1038/sj.bjp.0700929. View

3.
Bristow M, Ginsburg R, Minobe W, Cubicciotti R, Sageman W, Lurie K . Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982; 307(4):205-11. DOI: 10.1056/NEJM198207223070401. View

4.
Neumann J, Schmitz W, Scholz H, von Meyerinck L, Doring V, Kalmar P . Increase in myocardial Gi-proteins in heart failure. Lancet. 1988; 2(8617):936-7. DOI: 10.1016/s0140-6736(88)92601-3. View

5.
Wera S, Hemmings B . Serine/threonine protein phosphatases. Biochem J. 1995; 311 ( Pt 1):17-29. PMC: 1136113. DOI: 10.1042/bj3110017. View